Bravoxin inj. susp. s.c.

Země: Belgie

Jazyk: angličtina

Zdroj: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Aktivní složka:

Clostridium perfringens type A (alfa) toxoid >= 0,5 IU/ml; Clostridium sordellii toxoïd >= 4,4 U/ml; Clostridium perfringens type D (epsilon) toxoid >= 5,3 IU/ml; Clostridium septicum toxoid >= 4,6 IU/ml; Clostridium novyi toxoid >= 3,8 IU/ml; Clostridium perfringens, type B and C, beta toxoid >= 18,2 IU/dose; Clostridium haemolyticum toxoid >= 17,4 U/ml; Clostridium chauvoei (inactivated) ; Clostridium tetani toxoid >= 4,9 IU/ml

Dostupné s:

Intervet International B.V.

ATC kód:

QI02AB01

INN (Mezinárodní Name):

Clostridium Novyi Toxoid; Clostridium Tetani Toxoid; Clostridium Haemolyticum Toxoid; Clostridium Sordellii Toxoid; Clostridium Perfringens Type A, α Toxoid; Clostridium Perfringens Type B,C (beta) toxoid; Clostridium Perfringens Type D (epsilon) toxoid; Clostridium Chauvoei; Clostridium Septicum

Léková forma:

Suspension for injection

Složení:

Clostridium Novyi Toxoid; Clostridium Tetani Toxoid; Clostridium Haemolyticum Toxoid; Clostridium Sordellii Toxoid; Clostridium Perfringens Type A, α Toxoid; Clostridium Perfringens Type B,C (beta) toxoid; Clostridium Perfringens Type D (epsilon) toxoid; Clostridium Chauvoei; Clostridium Septicum

Podání:

Subcutaneous use

Terapeutické skupiny:

cattle; sheep

Terapeutické oblasti:

Clostridium; QI04AB01 Clostridium

Přehled produktů:

CTI code: 582062-01 - Pack size: 20 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 582062-03 - Pack size: 100 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 582062-02 - Pack size: 50 ml - Commercialisation status: YES - Delivery mode: Medical prescription

Stav Autorizace:

Commercialised: Yes

Datum autorizace:

2021-03-22